Oxford Nanopore Technologies Ltd, a developer of gene sequencing technology, has raised £31.4 million in new funding in a private placement of its ordinary shares. Nearly all of the funds have been supplied by the company’s existing investors. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals